Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Recurrence 4Immunoglobulin Light-chain Amyloidosis 4Neoplasms, Plasma Cell 3Hematologic Neoplasms 3Renal Insufficiency 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2beta-Thalassemia 1Waldenstrom Macroglobulinemia 1Thalassemia 1Plasmablastic Lymphoma 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm, Residual 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma 1Leukemia, Plasma Cell 1Leukemia, Biphenotypic, Acute 1Burkitt Lymphoma 1Anemia, Sickle Cell 1Amyloidosis 1Acute-Phase Reaction 1

Interventions

Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Acute-Phase Reaction × Bortezomib × Clear all
NCT06284395 2024-10-02

Two Schemes Response in Multiple Myeloma

Hospital General de Mexico

Recruiting
83 enrolled
Plasma cell

Acute-Phase Reaction, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡